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 ABSTRACT 
 
Lactose oxidase (LO) oxidizes lactose to lactobionic acid, producing H2O2 that could act as an 
antimicrobial and activate the lactoperoxidase system (LPS), an antimicrobial system present in 
milk. We evaluated the antimicrobial effect of LO alone and with the components of the LPS: 
SCN- and lactoperoxidase. An increase in LO caused higher reductions of Pseudomonas fragi in 
pasteurized milk. A total bacterial growth curve in raw milk showed a longer lag phase and lower 
counts when the LPS was activated by LO compared to the control. The antimicrobial effect of 
LO against foodborne pathogens and spoilage microorganisms was evaluated through an overlay 
inhibition assay. LO was applied in different media to evaluate the effect of lactose and SCN-. All 
the indicators were inhibited by LO in presence of lactose. However, SCN- had no effect on the 
inhibition. The antimicrobial effect was attributed to H2O2 produced from the oxidation of lactose.  
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CHAPTER 1 
 
LACTOSE OXIDASE:  A NOVEL ACTIVATOR OF THE LACTOPEROXIDASE 
SYSTEM IN MILK FOR IMPROVED SHELF-LIFE 
 
ABSTRACT 
 
The lactoperoxidase system (LPS) is an antimicrobial system naturally present in milk, that is 
activated by H2O2, and has been used to inhibit microbial outgrowth in raw milk in areas where 
refrigeration is not viable. This study evaluated lactose oxidase (LO) as a novel activator of the 
LPS. LO oxidizes lactose and produces H2O2 needed for the activation of the LPS. The 
antimicrobial effect of different concentrations of LO with and without and without components 
of the LPS system, NaSCN and lactoperoxidase (LP), was evaluated in model systems and then 
applied in pasteurized milk and raw milk. In general, an increase in LO caused higher reductions 
of P. fragi and treatments were more effective at 6 °C than at 21 °C. The LO solution at 0.12 and 
1.2 g/L showed a significantly higher microbial reduction than the control when added both alone 
and combined with the LPS components. At 21 °C, treatments with 1.2 g/L of LO solution 
achieved a reduction of >2.93 log CFU/mL, but at lower levels there was not a significant reduction 
from the control. Higher concentrations of NaSCN led to a greater P. fragi reduction at both 
temperatures when LO was added alone but not when combined with LP. In pasteurized milk, the 
LO solution at 0.12 g/L caused a reduction of P. fragi within 24 h of ~1.4 log when added alone 
and of ~2.7-log when combined with LP and NaSCN. Bacterial counts remained at significantly 
lower levels than the control during storage and the NaSCN- supplemented milk exhibited a ~ 6-
log difference from the control by day 7. The total bacterial growth curve in raw milk showed a 
longer lag phase when the LPS was activated by LO (11.3 h) compared to the control (4.0 h) but 
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it was not different from the recommended method (9.4 h). However, the total bacterial count after 
24 h for the LO-NaSCN-treated sample (5.3 log CFU/mL) was significantly lower compared to 
the control (7.2 log CFU/mL) and the recommended method (6.1 log CFU/mL). Results from this 
study suggest that LO is an alternative source of H2O2 that enhances the microbial inhibition 
achieved by the LPS. LO could be used to develop enzyme-based preservation technologies for 
applications where cold chain access is limited. This enzymatic approach to improve the shelf-life 
of dairy products also represents a novel option for a clean label spoilage control. 
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INTRODUCTION 
 
Milk is a nutrient-dense food, a characteristic that makes it a popular product in human diet but it 
also means it is very susceptible to microbial spoilage. Different methods, such as refrigeration 
and heat treatments, have been used to limit spoilage of fluid milk along the supply chain. The 
lactoperoxidase system (LPS), an antimicrobial system endemic to milk, represents an alternative, 
enzymatic-based preservation method to inhibit microbial growth and extend raw milk shelf life 
(Seifu et al., 2005). The use of this endogenous antimicrobial system is especially important in 
developing countries and rural areas, where refrigeration of milk before processing or consumption 
is not feasible due to its high cost, lack of electricity, or difficulties with maintenance and repair 
of the equipment (Seifu et al., 2005). The LPS enables extended milk storage at ambient 
temperatures and has shown to be more profitable than cooling for small scale dairy producers, 
and thereby improving their milk marketability, income, and employment opportunities 
(FAO/WHO, 2006). 
 
LPS consists of three components: lactoperoxidase (LP), thiocyanate (SCN-), and hydrogen 
peroxide (H2O2). The enzyme catalyzes the peroxidation of SCN- into hypothiocyanite (OSCN-) 
which is the main antimicrobial component, in combination with other intermediary products (De 
Wit and Van Hooydonk, 1996). The concentration of both SCN- and H2O2 in the milk impact the 
magnitude of the antimicrobial effect. LPS has been reported to have a bacteriostatic effect against 
Gram-positive bacteria such as streptococci and lactobacilli, as well as a bactericidal effect against 
Gram-negative bacteria like pseudomonads and coliforms (Kussendrager and van Hooijdonk, 
2007).  
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LP is a heat sensitive enzyme; its residual activity after HTST pasteurization is approximately 70 
% and UHT pasteurization inactivates it completely (Barret et al., 1999). The average 
concentration of LP in raw milk is 30 mg/L, while SCN- can vary between 1 and 15 mg/L 
depending on factors such as animal feed and breed of cow (Kussendrager and van Hooijdonk, 
2007). The natural concentration of H2O2 in milk, however, is not sufficient to activate the 
antimicrobial system. Therefore, methods to generate this substrate are required, and have 
included: i) the addition of sodium carbonate peroxyhydrate; ii) the activation of H2O2 producing 
systems such as glucose-glucose oxidase and xanthine-xanthine oxidase; and iii) the endogenous 
production of H2O2 by catalase negative microorganisms (Adolphe et al., 2006, FAO/WHO, 2006). 
 
Lactose oxidase (LO) oxidizes lactose to lactobionic acid with the concurrent reduction of O2 to 
H2O2 (Nordkvist et al., 2007). The enzyme used in this study was cloned from Microdochium 
nivale and expressed in Fusarium venenatum. Ahmad et al. (2004) concluded that it is safe to use 
lactose oxidase in food for human consumption. Currently, LO is primarily used for the production 
lactobionic acid, a compound used for the preservation of tissues by the medical industry due to 
its metal-chelating properties. Potential uses for the acid in the food industry are also as metal 
chelator, protein and fat replacer in cheese, and flavor enhancer (Ahmad et al., 2004). Its potential 
as an activator of LPS or as an antimicrobial agent in dairy products has not been studied. 
 
The first part of this study explored the effect of the concentration of lactose oxidase – alone and 
as an activator of the LPS – and of thiocyanate on the outgrowth of Pseudomonas fragi in UHT 
milk during storage at 6 °C and 21 °C. Pseudomonas spp. are one the most common spoilage 
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microorganisms associated with milk and dairy products due in part to their ability to grow under 
refrigeration conditions. Stellato et al. (2017) found that P. fragi and P. fluorescens are the most 
abundant species in dairy samples and processing plants. The generated data was then used as 
reference to select the concentration of lactose oxidase to use in two applications: (1) as 
antimicrobial in pasteurized milk spiked with P. fragi to mimic post-pasteurization contamination, 
and (2) as an activator of the LPS in raw milk in comparison with the method described by 
FAO/WHO (1991) to activate the system. The results of this study describe the application of LO 
as novel source of H2O2 that utilizes naturally present constituents of milk, lactose and oxygen, to 
enhance the microbial inhibition achieved by the LPS. LO could be used to create enzyme-based 
preservation technologies to improve the shelf-life of dairy products or for applications where cold 
chain access is limited. 
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MATERIALS AND METHODS 
 
Inoculum preparation 
 
A frozen stock of a Pseudomonas fragi isolated from pasteurized milk was obtained from the 
Cornell University Food Safety Laboratory isolate collection. The frozen culture was streaked onto 
brain heart infusion agar (BHI; Difco, BD Diagnostics, Franklin Lakes, NJ) and incubated at 32 ± 
1°C for 24 h. An individual colony was then used to inoculate 5 mL of BHI broth, followed by 18 
h of incubation at 32 ± 1°C. A 1-mL aliquot of the overnight culture was transferred to a 1.5 mL 
Eppendorf tube and centrifuged for 1 min at 14,000 g. The supernatant was removed and the cell 
pellet was re-suspended in 1 mL of phosphate buffered saline solution (Weber Scientific, Trenton, 
NJ) and then used as the inoculum. 
 
Evaluation of the concentration of lactose oxidase 
 
One liter of ultra-pasteurized (UHT) skim milk (Parmalat USA Corp, Grand Rapids, MI) was 
inoculated with P. fragi to obtain an approximate load of 4 log CFU/mL. The initial bacterial 
concentration was confirmed by plating the inoculated milk immediately after inoculation. Bovine 
lactoperoxidase (Sigma-Aldrich, Co., St. Louis, MO) and NaSCN (VWR International, LLC, 
Solon, OH) were added to 330 mL of inoculated milk to a final concentration of 30 mg/L and 14 
mg/L, respectively. NaSCN was added as a solution (4.6 w/v %) previously prepared in distilled 
water and filter-sterilized through a surfactant-free cellulose acetate (SFCA) filter of 0.20 µm pore 
size (Corning Incorporated, Corning, NY). An enzymatic solution of lactose oxidase 
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(LactoYIELD®, Chr. Hansen, Milwaukee, WI) was then added at concentrations of 0.012, 0.12 
and 1.2 g/L to individual 70-mL volumes of both the inoculated milk and the NaSCN 
supplemented milk, to obtain a total of six different treatments. Samples were aliquoted into 
separate test tubes for every time point and were then incubated at 6 ± 1°C or 21 ± 1 °C. Samples 
were plated for microbiological load after 1, 2, 4, and 7 days of storage. The experiment was 
carried out in triplicate and inoculated milk with no LPS/NaSCN supplementation or added 
enzyme was used as the control. 
 
Evaluation of the concentration of thiocyanate  
 
One liter of ultra-pasteurized (UHT) skim milk (Parmalat USA Corp, Grand Rapids, MI) was 
inoculated with P. fragi to obtain an approximate load of 4 log CFU/mL. The initial bacterial 
concentration was confirmed by plating the inoculated milk immediately after inoculation. Bovine 
lactoperoxidase (Sigma-Aldrich, Co., St. Louis, MO) was added to 330 mL of the inoculated milk 
to a final concentration of 30 mg/L. NaSCN was then added to individual 70-mL aliquots of both 
milk fractions to reach final concentrations of 14, 140 and 1400 mg/L; followed by the addition of 
the lactose oxidase solution (LactoYIELD®, Chr. Hansen, Milwaukee, WI) at 0.12 g/L to all milk 
samples to obtain a total of six different treatments. NaSCN was added as a solution (32.7 w/v %) 
previously prepared in distilled water and filter-sterilized through a SFCA 0.20 µm pore size filter. 
Samples were aliquoted into separate test tubes that were then incubated at 6 ± 1°C or 21 ± 1 °C. 
Samples were plated for microbiological load after 1, 2, 4, and 7 days of storage. The experiment 
was carried out in triplicate and inoculated milk with no LPS/NaSCN supplementation or added 
enzyme was used as the control. 
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Application of lactose oxidase in pasteurized milk 
 
One liter of pasteurized skim milk (Cornell Dairy, Ithaca, NY) was inoculated with P. fragi to 
obtain an approximate load of 4 log CFU/mL. Lactose oxidase (LactoYIELD®, Chr. Hansen, 
Milwaukee, WI) was incorporated into individual 70-mL samples at concentrations of 0.006, 0.012 
and 0.12 g/L. NaSCN solution was added to 300 mL of inoculated milk to a concentration of 14 
mg/L, and afterwards, lactose oxidase was added to three 70-mL samples at the same three 
concentrations previously mentioned. NaSCN was added as a solution (4.6 w/v %) previously 
prepared in distilled water and filter-sterilized through a SFCA 0.20 µm pore size filter. Samples 
were aliquoted into separate test tubes that were then incubated at 6 ± 1°C. Samples were plated 
for microbiological load after 0, 1, 2, 4, and 7 days of storage. The pH was measured for all samples 
at the same time points. The experiment was carried out in triplicate and inoculated milk with no 
LPS/NaSCN supplementation or added enzyme was used as the control. 
 
Application of lactose oxidase as raw milk preservative 
 
Whole raw milk was collected from Cornell’s Teaching Barn (Cornell University, Ithaca, NY) 
within 1 hour from the time of milking. The bottle containing the milk was inverted 25 times before 
dividing it in three separate 1-L samples. The first sample was prepared following the process 
described by FAO/WHO (1991), which consists on the addition of 14 mg/L of NaSCN and 30 
mg/L of sodium percarbonate. NaSCN was added as a solution (0.028 g/mL) prepared in distilled 
water and filter-sterilized through a SFCA 0.20 µm pore size filter. A solution of sodium 
percabonate (0.06 g/mL) in sterilized distilled-deionized water was immediately added after being 
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prepared. The second milk sample was prepared adding NaSCN and lactose oxidase 
(LactoYIELD®, Chr. Hansen, Milwaukee, WI) solutions to reach final concentrations of 14 mg/L 
and 0.12 g/L, respectively. The third sample was prepared adding the lactose oxidase solution at a 
concentration of 0.12 g/L. All samples were incubated at 21 ± 1 °C for 24 h and a total microbial 
count was carried out every two hours for the first 12 hours of incubation, and every four hours 
for the remaining time. The pH was measured for all samples at the same time points. The 
experiment was carried out in triplicate and inoculated milk with no supplementation or added 
enzyme was taken as the control. 
 
Microbiological analysis 
 
Serial dilutions of the milk samples were prepared in phosphate buffer and spread in duplicate on 
Standard Plate Count agar. Plates were incubated at 32 ± 1 °C for 48 h before enumeration.  
 
Statistical analysis 
 
All statistical analyses were performed using R (version 3.4.1, R Development Core Team, 
Vienna, Austria). An ANOVA and a Tukey’s honest significant difference test were performed 
individually for each time point to compare the log differences in microbial counts between 
treatments corresponding to the evaluation of the concentration of LO and NaSCN, as well as from 
the application of LO in pasteurized milk. To analyze the data obtained from the application of LO 
in raw milk, Buchanan growth curve models with no Nmax parameter were fit using the nlsMicrobio 
and nlstools packages in R. Using the confint2 function of nlstools, asymptotic 95 % confidence 
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intervals were calculated for the lag phase, maximum growth rate and initial concentration for 
every treatment. Estimates were regarded as significantly different if the 95 % confidence intervals 
did not overlap. In addition, an ANOVA and a Tukey’s honest significant difference test were 
performed to compare the total microbial counts between treatments at 24 h. A count from the 
evaluation of the concentration of SCN- (14 mg/L SCN-, 0.12 LO solution, day 7) was considered 
an outlier based on results from previous experiments and on other three independent replicates of 
the same treatment. 
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RESULTS AND DISCUSSION 
 
Concentration of LO 
 
Different concentrations of a LO solution were evaluated to determine the effectiveness inhibiting 
the growth of P. fragi in skim milk. For this study, a P. fragi strain isolated from pasteurized milk 
was selected as the indicator of microbial inhibition. The LO solution was added by itself to 
determine if it had an antimicrobial effect due H2O2 production, as well as in combination with 
NaSCN and LP to evaluate its potential as an activator of LPS.  
 
 
 
*Bars with different letters indicate significant difference (p<0.001) between treatments on the same day. 
**For counts lower than the limit of detection, a value of 1 log10 CFU/mL was used for the statistical analysis. 
Figure 1. P. fragi counts in skim milk treated with LO and LPS during storage at (a) 6 °C and (b) 21 °C. 
 
At 6 °C the increase in the concentration of LO caused higher reductions of P. fragi during 7 days 
of storage (Figure 1). When the LO solution was added at 0.012 g/L, P. fragi counts were in 
general lower than the control for the first 48 h of storage. However, by days 4 and 7 bacterial 
counts for both LO and LPS treatments were no different than the control. At this lowest LO 
concentration, no significant difference was determined between the addition of the oxidase alone 
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or combined with the LPS components by the end of the study. Samples treated with 0.12 g/L of 
LO showed an initial ~2.5 log reduction of P. fragi within 24 h followed by a slight increase of 
less than 1 log by day 7. The counts for this treatment were consistently lower than the control. 
The same bactericidal effect within 24 h was achieved when LO was used at 0.12 g/L in presence 
of LP and NaSCN. In addition, this treatment had a bacteriostatic effect on P. fragi during the 
remaining days of storage and counts were significantly lower compared to LO by itself on days 
4 and 7. A reduction of P. fragi below the detection limit was achieved in 24h when the LO solution 
was added at 1.2 g/L no regrowth occurred after 7 days of storage. At this concentration, no 
significant difference was determined between the antimicrobial effect of LO added independently 
or combined with the LPS components. Results suggest that at this concentration of LO solution 
the production of H2O2 was enough to kill P. fragi below the detection limits regardless of the 
presence of the LPS. 
 
None of the systems containing LO solution at 0.012 g/L had inhibitory effect on the growth of P. 
fragi at room temperature. At a concentration of 0.12 g/L, LO alone showed bacteriostatic effect 
for 24 h followed by regrowth to a concentration no significantly different than the control or its 
LPS counterpart. As observed for treatments at 6 °C, a concentration of LO solution of 1.2 g/L, 
exhibited bactericidal activity and P. fragi was reduced to undetectable concentrations within 24 
h with no regrowth after 7 days.  
 
The improved antimicrobial activity as the LO concentration increased could be caused by a higher 
production of H2O2. This compound acts as antimicrobial and as a substrate of the LPS that 
promotes the oxidation of SCN- to OSCN-. Martin et al. (2014) reported that the higher the 
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concentration of H2O2 in raw milk, the greater the antimicrobial effect on total bacterial count over 
time during storage at 6 °C and 21 °C. Similarly, Listeria monocytogenes growth was only 
inhibited in raw milk during 21 d at a concentration of 100 ppm of H2O2, while at concentrations 
of 400 and 800 ppm counts were reduced to undetectable levels within 24 h (Kozak et al., 2017). 
Other studies have reported bacterial inhibition due to the production of H2O2 by enzymatic 
systems such as glucose oxidase-glucose in milk (Dionysius et al., 1992) and liquid whole egg 
(Dobbenie et al., 1995). 
 
Gram-negative microorganisms such as pseudomonads can be both inhibited by the compounds 
produced by the LPS and killed by the H2O2 (De Wit and Van Hooydonk, 1996), which may 
explain the enhanced antimicrobial effect observed when LO was added in presence of SCN- and 
LP. Reiter et al. (1976) studied the activation of the LPS using glucose oxidase and reported that 
the bactericidal effect occurred in two stages: the first one because of SCN- oxidation by LP, and 
the second due to the accumulation of H2O2. This combined effect is also consistent with a previous 
study that showed greater antimicrobial activity against Staphylococcus aureus, P. aeruginosa, 
and Bacillus cereus for the LPS compared with H2O2 alone (Fweja et al., 2008). Our results also 
indicate that the natural concentration of lactose in milk is adequate to promote the production of 
H2O2 via LO and obtain the described antimicrobial effect.  
 
All treatments were more effective inhibiting the growth of P. fragi in milk at refrigeration 
temperature than at room temperature (Figure 1), except at a concentration of 1.2 g/L of enzymatic 
solution. These results are in agreement with those reported by Martin et al. (2014), where H2O2 
showed higher bacterial inhibitory effect at 6 °C than at 21 °C. Although SCN- peroxidation is 
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higher at room temperature than at refrigeration temperatures (Adolphe et al., 2006), it is likely 
that the concentration of the antimicrobial product was not sufficient to inhibit growth of P. fragi 
under conditions that promote more active bacterial growth. FAO/WHO (2006) specify that the 
inhibitory effect of the LPS depends on the storage temperature of the milk, ranging from 5- 6 days 
at 4 °C and 16-17 h at 20 °C. Results from this study were consistent with those observations.  
  
Concentration of NaSCN 
 
The principal antimicrobial compound produced by the LPS is hypothiocyanite (OSCN−) and it is 
the result of the peroxidase-catalazed oxidation of SCN-. This compound, known as a hypo-
pseudo-halide, is a potent oxidant with antimicrobial activity (Bafort et al., 2014). OSCN− oxidizes 
the sulphydryl groups of proteins to disulphides causing structural damage of microbial 
cytoplasmatic membranes (Kussendrager and van Hooijdonk, 2007). The antimicrobial activity of 
the LPS is affected both by the concentration of SCN- and by the method used to generate H2O2 
since they affect the concentration of OSCN− and the LP activity (Dionysius et al., 1992). 
 
Based on observations from preliminary studies, we hypothesized that the level of SCN- affects 
not only the activity of the LPS, but might also influence the activity of LO. Various SCN- were 
evaluated to study its effect on the antimicrobial activity of LO alone and combined with LP.  All 
treatments had bactericidal effect at 6 °C during the first 48 h and in general, there was no 
significant difference between samples treated with LO only or with the LPS. LO-treated samples 
exhibited bactericidal effect over time with counts ~7 log lower than the control by day 7. At 
NaSCN concentrations of 140 and 1400 mg/L, P. fragi was reduced below the detection limit after 
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4 d. Similarly, the activation of the LPS with 14 mg/L of NaSCN also showed bactericidal activity 
during 7 d of storage and counts were no significantly different compared with the LO treatments. 
In contrast, LPS treatments at 140 and 1400 mg/L of NaSCN exhibited regrowth on day 7. Counts 
for these two treatments were significantly lower than the control at every time point; however, 
they were significantly less effective at inhibiting growth of P. frigi than LO alone or with the LPS 
activated with 14 mg/L of NaSCN. 
  
 
*Bars with different letters indicate significant difference (p<0.001) between treatments on the same day.  
**For counts lower than the limit of detection, a value of 1 log10 CFU/mL was used for the statistical analysis. 
 
Figure 2. P. fragi counts in skim milk treated with LO and LPS at different concentrations of NaSCN 
during storage at (a) 6 °C and (b) 21 °C. 
 
At 21 °C, the higher the concentration of SCN-, the greater the antimicrobial effect of the LO 
enzyme over storage time. The combination of SCN- at 14 mg/L and LO exhibited a bacteriostatic 
effect for 24 h followed by regrowth of P. fragi to concentrations not significantly different than 
the control. However, LO combined with 140 and 1400 mg/L of NaSCN showed bactericidal 
activity. In the first case, P. fragi was gradually reduced over time until reaching a concentration 
below the detection limit on day 7. For the latter, P. fragi levels were reduced below the detection 
limits within 24 h and no regrowth was detected after 7 d. In contrast, the concentration of SCN- 
did not have a significant effect on the antimicrobial activity of the LPS at room temperature. The 
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inhibition of P. fragi did not increase significantly with the addition of higher levels of SCN- except 
on day 7 at the highest concentration, however, outgrowth was not inhibited. 
 
Interestingly, results shown in Figure 2 showed reduced inactivation of P. fragi at both 
temperatures when LP was present in comparison to systems with LO and SCN- alone, particularly 
at increased levels of SCN-. One explanation for the reduced antimicrobial activity of the LPS at 
the two higher levels of NaSCN evaluated in this study is that LP function can be inhibited by an 
excess level of SCN-. The anion can bind to the native enzyme, restricting the binding site to H2O2, 
and altering the following reactions that lead to the production of antimicrobial compounds by the 
LPS (Bafort et al., 2014). Dionysius et al. (1992), however, reported that increasing the 
concentration of SCN- caused only a slight increase in the production of the oxidation product, and 
suggested that the production of H2O2 was the rate limiting factor in the enzymatic reaction.  In 
both conditions, LO is producing H2O2. In the LP-free conditions, H2O2 is the primary 
antimicrobial agent.  If in the LP and LO containing conditions, the higher levels of SCN- were 
inhibiting LP activity the non-utilized H2O2 would be free to act as an antimicrobial compound as 
in the LP-free condition and one might expect to see similar levels of inhibition, but this was not 
observed. These results suggest an interaction or potential synergistic effect between LO and SCN- 
that improved the inactivation of P. fragi in absence of LP. To control for the effect of SCN- on P. 
fragi counts, milk samples were exposed to all three different concentrations of NaSCN. Counts 
for NaSCN-controls were not significantly different than the control (data not shown), which 
means that NaSCN had no antimicrobial activity individually and reinforces the theory of a 
synergistic effect with LO. The influence of SCN- on LO activity has not been studied and future 
research is needed to understand this potentially new mechanism of inhibition.  
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These results suggest that the addition of both LO and SCN- could be studied as a potential 
antimicrobial system in other food matrixes. Data from this study showed that both temperature 
and SCN- concentration affect the bacterial reduction achieved by the LO-SCN- system. It should 
be noted that when looking to add SCN- some studies suggest that high levels of SCN- can interfere 
with iodine metabolism and reduce its uptake by the thyroid gland (FAO/WHO, 2006). However, 
the effect is adverse only in individuals with iodine deficiency (Laurberg et al., 2009).  In addition, 
a concentration of NaSCN around 20 mg/L, which proved to be effective in this study, is 10-20 
times lower than the level that has shown to have an effect on iodine metabolism (FAO/WHO, 
2006). 
 
Application of lactose oxidase in pasteurized milk 
 
Pseudomonas spp. is the most common bacteria associated with post-pasteurization contamination 
(PPC) of fluid milk, a problem that affects approximately 50 % of the supply (Martin et al., 2018). 
Pasteurized skim milk was spiked with P. fragi and then treated with LO alone or combined with 
NaSCN to evaluate the interaction with the native LPS that remains active after HTST 
pasteurization. A maximum concentration of 0.12 g/L of LO solution was selected based on 
previous results (Figure 1) and considering the potential impact of the enzyme concentration on 
sensory attributes and costs. Lower concentrations were also tested to determine if there was an 
antimicrobial effect when applied in a commercial sample in comparison with the model systems. 
NaSCN was added at 14 mg/L based on results shown in Figure 2a and the usage recommendations 
by FAO/WHO (1991). 
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*Bars with different letters indicate significant difference (p<0.001) between treatments on the 
same day. 
**For counts lower than the limit of detection, a value of 1 log10 CFU/mL was used for the 
statistical analyses. 
 
Figure 3. P. fragi counts in pasteurized milk treated with LO and LPS during storage at 6 °C.  
Table 1. pH of pasteurized milk treated with lactose oxidase during storage at 6 °C. 
TREATMENT 
TIME (DAYS) 
1 4 7 
Control 6.73 ± 0.02 6.71 ± 0.03 6.71 ± 0.02 
LO 0.006 6.71 ± 0.02 6.67 ± 0.01 6.65 ± 0.02 
LO 0.012 6.70 ± 0.03 6.64 ± 0.02 6.60 ± 0.02 
LO 0.12 6.66 ± 0.03 6.56 ± 0.02 6.44 ± 0.03 
T-LO 0.006 6.71 ± 0.03 6.66 ± 0.05 6.63 ± 0.06 
T-LO 0.012 6.70 ± 0.03 6.65 ± 0.03 6.60 ± 0.03 
T-LO 0.12 6.65 ± 0.03 6.55 ± 0.04 6.46 ± 0.04 
 
Figure 3 shows that concentrations of 0.006 g/L and 0.012 g/L of the LO solution caused no 
significant effect on P. fragi counts compared to the control and no significant difference was 
determined between adding LO with or without NaSCN supplementation. This contrasts with 
results shown in Figure 1, where the addition of the enzyme solution at a concentration of 0.012 
g/L showed antimicrobial activity during 48 h regardless of the concentration of NaSCN. Results 
suggest that production of H2O2 at these concentrations was not sufficiently high as to activate the 
LPS or act as an antimicrobial. The discrepancy between results could be due to a difference 
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between the activity of LP present in the model systems and in the pasteurized milk. HTST 
pasteurization reduces up to 30 % of LP activity (De Wit and Van Hooydonk, 1996, Barret et al., 
1999), which has direct impact on its antimicrobial power.  
 
The LO solution added at 0.12 g/L reduced P. fragi counts within the first 24 h at both levels of 
NaSCN. The LO-treated milk showed an initial reduction of ~ 1.4 log and counts remained 
relatively constant with a difference of less than 1 log between counts for during 4 days. Regrowth 
occurred by day 7 but P. fragi counts were still significantly lower compared to the control. The 
addition of SCN- to activate the LPS system caused a ~ 2.7-log reduction of P. fragi after 24 h. 
Counts increased ~ 1 log by day 4 and 7 but never exceeded the initial inoculum level. By day 7, 
the supplemented milk exhibited a ~ 6-log difference from the control and significantly lower 
counts compared with the rest of treatments. Supplementation with NaSCN enhanced the 
antimicrobial effect of the LPS and helped maintaining P. fragi at low levels during storage 
compared to the LO-treated sample. This effect was not unexpected since 8 mg/L is the average 
concentration of SCN- in bulked milk and 15 mg/L are required for the activation of the LPS (Seifu 
et al., 2005, FAO/WHO, 2006). 
 
According to the results, the remaining activity of LP after pasteurization is sufficient to achieve 
important microbial reductions. LO could be added to pasteurized milk to extend its shelf-life or 
to inhibit spoilage in case of PCC. In this study, the initial inoculum level was high and close to 
the Pasteurized Milk Ordinance (PMO) SPC limit of 20,000 CFU/mL. However the initial level 
of PCC is in general very low (Schröder, 1984) and could be inhibited by a reduced concentration 
of LO. FAO/WHO (2006) explain that the antimicrobial effect of the LPS is inversely correlated 
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to bacterial concentration. Its efficacy is low at high bacterial levels, bacteriostatic at intermediate 
levels, and bactericidal at low levels.  
 
The impact of the addition of LO on the sensory attributes of milk should be noted. The production 
of lactobionic acid causes a decrease in the pH of milk and it could also potentially change its 
flavor. Table 1 shows that the lowest pH of pasteurized milk dropped to 6.46 after 7 days of storage 
for the most effective treatment (T-LO 0.12). However, longer storage periods or higher 
concentrations of enzyme might cause a more dramatic effect that impacts both sensory quality 
and functionality of milk. Technologies such as enzyme immobilization could be explored as an 
option to control the contact time between the milk and the enzyme to achieve the desired 
antimicrobial effect while controlling the production of acid. 
 
Application of lactose oxidase as a raw milk preservative 
 
The addition of LO as an activator of the LPS was compared to the reference method described in 
the guidelines by FAO/WHO (1991) to activate the antimicrobial system in raw milk. The 
FAO/WHO method consists on the addition of 14 mg/L of NaSCN and 30 mg/L of sodium 
percarbonate as the source of H2O2. Previous results from this study were used as reference and 
LO was added at 0.12 g/L both alone and in addition to 14 mg/L of NaSCN. Milk was stored at 21 
°C and total bacterial growth monitored for 24 (Figure 4) to compare the results with the 16–17 h 
range of microbial inhibition reported by FAO/WHO (1991, 2006) at that temperature. 
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Figure 4. Total bacterial growth curve in raw milk stored at 21 °C. 
 
Table 2. Parameters determined from the total bacterial growth curve in raw milk stored at 21 °C. 
TREATMENT 
LAG 
PHASE* 
(H) 
MAX GROWTH RATE 
(H-1) 
24-H 
COUNT** 
(LOG CFU/ML) 
24-H  
PH  
 
CONTROL 4.0 ± 1.0a 0.50 ± 0.04 7.21 ± 0.07c 6.68 ± 0.01 
FAO/WHO  9.4 ± 1.0b 0.49 ± 0.05 6.09 ± 0.12b 6.72 ± 0.01 
LO 5.4 ± 0.9a 0.51 ± 0.03 7.06 ± 0.08c 6.66 ± 0.01 
LO-T- 11.3 ± 1.4b 0.42 ± 0.07 5.34 ± 0.30a 6.67 ± 0.01 
* Means with different letters indicate significant difference (p<0.05) between treatments. 
**Means with different letters indicate significant difference (p<0.0001) between treatments. 
 
The average lag phase was significantly longer for the samples treated with both LO and SCN - 
than the control and LO alone, but not significantly different from the reference method (Table 2). 
The average maximum growth rate during the exponential phase was 0.48 h-1, and no significant 
difference was determined among treatments. However, the total bacterial count after 24 h for the 
LO+SCN-treated sample was significantly different lower compared to the other treatments. The 
final count was ~ 1.8-log lower than the control and LO added alone, and ~ 0.8 log lower compared 
to the reference method. This is consistent with reports that mention that the production of H2O2 
by enzymatic systems such as glucose oxidase/glucose, and xanthine oxidase/hypoxanthine may 
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improve the antimicrobial activity of the LPS compared to added H2O2 (Kussendrager and van 
Hooijdonk, 2007). According to Dionysius et al. (1992), the H2O2/OSCN- ratio is low when an 
enzymatic method is used to generate H2O2 and that promotes OSCN- as the main oxidation 
product. When the ratio is high, excess H2O2 oxidizes OSCN- leading to the formation of other 
compounds with no antimicrobial activity. This could explain the enhanced antimicrobial activity 
achieved when the LO-lactose system was used as the activation method. It should be noted that 
LO activated the LPS and microbial growth was inhibited regardless the higher fat content of this 
sample in contrast with skim milk samples used in previous experiments. 
 
Consistently with previously discussed results, supplementation with NaSCN improved the 
antimicrobial effect of the LPS. Probably, the concentration of SCN- in the milk was not sufficient 
to activate the LPS and therefore the addition of LO alone showed no significant difference in the 
evaluated parameters compared to the control. Overall, the LPS activation method adding LO and 
SCN- showed the most potential for preservation of raw milk stored under abused temperature and 
its inhibition effect is comparable to the method of reference.  
 
An advantage of the application of LO as an activator of the LPS is that lactose, its substrate, is 
naturally present in milk. On the contrary, the use of other enzymatic systems might imply the 
addition of excess sugars such as glucose. Another promising result is that, as shown in Table 2, 
after 24 h the pH for the sample treated with LO and NaSCN was still around 6.7, which is the 
normal value for fresh milk (Walstra et al., 2005). Since the activation of the LPS does not 
substitute pasteurization (FAO/WHO, 1991), heat treating the raw milk would cause the 
inactivation of LO and thus stop further production of acid.  
  23 
CONCLUSION 
 
Results from this study suggest that LO can act as an alternative source of H2O2 that enhances the 
microbial inhibition achieved by the LPS, and may work synergistically with SCN- in the absence 
of LP. LO could be used to create enzyme-based preservation technologies for applications in 
locations where cold chain access is limited. Additionally, LO proved to be effective under 
refrigeration conditions, showing that it could be used as a preservative in situations where raw 
milk needs to be held for extended periods of time before pasteurization and further processing. 
Additional studies should address methods, such as enzyme immobilization, to prevent pH drop in 
the milk for applications of LO in final products like pasteurized milk. Finally, since enzymes are 
present in diverse dairy foods, the application of LO as an antimicrobial represents an opportunity 
for the dairy industry to benefit from an extended the shelf-life of their products while meeting the 
consumer desire for clean labels.  
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CHAPTER 2 
 
INHIBITION OF FOODBORNE PATHOGENS AND SPOILAGE MICROORGANISMS 
ASSOCIATED WITH DAIRY PRODUCTS BY LACTOSE OXIDASE 
 
ABSTRACT 
 
The inhibitory effect of lactose oxidase on the growth of foodborne pathogens and spoilage 
microorganisms associated with dairy products was evaluated through an overlay inhibition assay. 
Lactose oxidase generates hydrogen peroxide via lactose oxidation into lactobionic acid. 
Escherichia coli O157:H7, Listeria monocytogenes, Salmonella enterica Ser. Tyhphimurium, 
Staphylococcus aureus, Pseudomonas fragi, and Penicillium chrysogenum were used as 
indicators. A commercially available solution of lactose oxidase was applied at different 
concentrations (0, 0.12, 1.2, and 12 g/L) in four types of media (BHI, BHI+NaSCN, BHI+lactose, 
and BHI+NaSCN+lactose) to evaluate the effect of lactose and SCN- on the microbial inhibition. 
LO inhibited the growth of all the indicators at a concentration of 12 g/L of the enzyme solution 
in the presence of lactose alone and in combination with NaSCN. However, supplementation with 
NaSCN had no effect on the magnitude of the microbial inhibition. S. aureus was the most sensitive 
pathogen and P. fragi was the most sensitive of all the indicators in general. L. monocytogenes and 
P. fragi showed higher susceptibility to the antimicrobial effect of LO at 6 °C than at their 
corresponding optimum growth temperature. The inhibitory effect was attributed to the generation 
of hydrogen peroxide from the oxidation of lactose by LO. Findings from this study demonstrate 
that LO could be used as a novel approach to inhibit the growth of mold and bacteria. It could also 
be applied as a label-friendly preservative not only in dairy foods but also in products 
supplemented with lactose. 
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INTRODUCTION 
 
Foodborne pathogens cause around 9.4 million illnesses; 56,000 hospitalizations; and 1,350 deaths 
in the United States each year (CDC, 2016). Specifically, dairy products were attributed 657,000 
of the foodborne illnesses caused by pathogenic bacteria between 1998 and 2008 (Painter et al., 
2013). Some of the prevalent pathogens associated with dairy foods are Salmonella spp., 
Escherichia coli, Listeria monocytogenes, Campylobacter spp., and Staphylococcus aureus (Lu 
and Wang, 2017). The presence of these pathogens in dairy products can be due to a faulty 
pasteurization, contaminated processing environment and equipment, and poor hygiene practices 
of food handlers (Oliver et al., 2005, Fernandes, 2009). For example, grated Parmesan cheese was 
recalled because of potential contamination with Salmonella (FDA, 2016), S. aureus and L. 
monocytogenes have been the cause of Queso Fresco recalls, and contamination with L. 
monocytogenes caused an ice cream recall (CDC, 2018).  
 
Food loss is another major issue for the dairy industry and microbial spoilage is one of the main 
contributors (Sperber, 2009). More than 24 billion pounds of dairy products went to waste in 2010 
and dairy was the food group with the largest loss at the retail level (Buzby et al., 2014). Common 
sources of spoilage microflora are raw milk; water, air and surfaces in contact with the product; 
and brines (Ledenbach and Marshall, 2009). Psychrotrophic bacteria represent the main cause of 
spoilage of dairy products and Pseudomonas spp. is one of the predominant species due to their 
ability to grow under refrigeration conditions (Lu and Wang, 2017). Pseudomonas growth causes 
off-flavors and off-odors due to the production of enzymes that degrade proteins and lipids 
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(Ledenbach and Marshall, 2009), as well as color changes in the surface of dairy products like 
cheese (Martin et al., 2011).  
 
Molds are also a common cause of spoilage dairy products such as cheese and yogurt. Molds can 
grow under acidic conditions in fermented dairy products were bacterial growth is inhibited and 
cause visual surface changes in color, odor, and flavor (Lu and Wang, 2017). Penicillium spp. is 
the most commonly reported spoilage genus (Garnier et al., 2017) and it has been found in vacuum-
sealed cheese stored under refrigeration (Lu and Wang, 2017). Studies have shown that some 
Penicillium strains are resistant and able to metabolize sorbate, a common cheese preservative, 
and develop off-odors and off-flavors (Ledenbach and Marshall, 2009, Garnier et al., 2017). 
 
The implementation of good manufacturing practices and the application of technologies such as 
pasteurization, air filtration, and modified atmospheres has reduced both spoilage and the number 
of outbreaks caused by dairy products. Nevertheless, post-processing contamination remains an 
issue for the food industry and there is a need for technologies to control it (Boor et al., 2017, 
Garnier et al., 2017). Preservatives such as sorbic acid, benzoic acid, and acetic acid, as well as 
antibiotics such as nisin and natamycin have aid the dairy industry in preventing bacteria and mold 
growth during storage (Herr, 2011). However, with the increasing consumer demand for clean 
labels and “natural” products, it is a challenge for the industry to prevent spoilage and pathogen 
growth without adding preservatives.  
 
Enzyme-based preservation technologies represent a clean label approach to preserve dairy foods. 
Enzymes are already part of their ingredient list since they widely used in dairy applications such 
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as milk coagulation and cheese ripening. Lactose oxidase (LO) generates hydrogen peroxide, a 
well-known antimicrobial compound, as a product of the oxidation of lactose to lactobionic acid 
(Nordkvist et al., 2007). Hydrogen peroxide has proven to be an effective antimicrobial in foods 
such as leafy greens (Moore et al., 2011), milk (Martin et al., 2014, Kozak et al., 2017), and queso 
fresco (Kozak et al., 2018), among others. However, the addition of hydrogen peroxide is not 
aligned with current consumer trends and is not always feasible or permitted depending on the 
product.  
 
In a previous study, LO showed bactericidal effect against Pseudomonas fragi in milk and a 
synergistic effect with thiocyanate (SCN-). However, its antimicrobial activity against foodborne 
pathogens and other spoilage microorganisms like molds has not been investigated. The objective 
of this study was to evaluate the antimicrobial effect of LO against pathogens and spoilage 
microorganisms associated with milk and dairy products.  
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MATERIALS AND METHODS 
 
Indicator strains 
 
Four foodborne pathogens, one spoilage microorganism and one mold (Table 3) were used to 
determine the antimicrobial activity of LO (LactoYIELD®, Chr. Hansen, Milwaukee, WI) in 
different media. For all the bacterial strains, a frozen culture was streaked onto brain heart infusion 
agar (BHI; Difco, BD Diagnostics, Franklin Lakes, NJ) and incubated for 24 h at 37 °C for 
pathogens and 32 °C for P. fragi. An individual colony was then used to inoculate 5 mL of BHI 
broth, followed by 18 h of incubation at the same temperatures previously mentioned. The mold 
was spot plated onto Malt Extract Agar (Difco, BD Diagnostics, Franklin Lakes, NJ) and incubated 
at 25 °C for 4 weeks. Spore formation was confirmed by microscopy. Spores were harvested by 
adding sterile water with 0.1% Tween 80 (Baker Analyzed, Philipsburg, NJ) to the plate and 
scraping the wet surface with a sterile spreader. The spores and mycelia were filtered through 
sterile cheesecloth into a sterile bottle to isolate spores only. The suspensions were combined with 
glycerol at 50 % (v/v) and stored at -80 ± 2 °C until use.  
 
Table 3. Classification and growth temperatures for microorganisms used as indicators 
Microorganism Classification Incubation temperature (°C) 
Escherichia coli O157:H7 (ATCC 43889) a Pathogenic 37 
Listeria monocytogenes b Pathogenic 37 
Salmonella enterica Ser. Tyhphimurium (ATCC14028) b Pathogenic 6 and 37 
Staphylococcus aureus (ATCC 8095) a Pathogenic 37 
Pseudomonas fragi b Spoilage 6 and 32 
Penicillium chrysogenum a Spoilage 25 
a From the Food Safety Laboratory, Cornell University, Ithaca, NY 
b From the collection of Dr. Randy Worobo’s, Cornell University, Geneva, NY 
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Overlay inhibition assay 
 
Four different types of media were used to test the inhibitory effect of lactose oxidase: BHI, BHI 
supplemented with NaSCN (14 mg/L), BHI supplemented with lactose (2.5 % m/v), and BHI 
supplemented with both NaSCN (14 mg/L) and lactose (2.5 % m/v). NaSCN and lactose were 
added to the media after sterilization in a solution previously filter-sterilized through a SFCA 0.20 
µm pore size. The well diffusion method described by Ahn and Stiles (1990) was followed to test 
the antimicrobial effect of four different concentrations (0, 0.12, 1.2, and 12 g/L) of the lactose 
oxidase solution. Wells (8 mm-diameter) cut into each type of media were filled with 100 µL of 
enzyme solution and allowed to diffuse into the agar in a laminar flow hood. Once the solution 
had been completely absorbed, a 5 µL aliquot of catalase (Sigma Aldrich, St. Louis, MO) was 
spotted next to the well to determine if the antimicrobial effect was caused by hydrogen peroxide. 
Plates were overlaid with a 10-mL aliquot of 0.75 % agar inoculated with 100 µL of 18-h culture 
for bacteria or spore suspension. Plates were incubated at 37 °C for all the pathogens, at 32 °C for 
P. fragi, and at 6 °C for L. monocytogenes and P. fragi because of their ability to grow under 
refrigerated conditions. For P. fragi, the assay was replicated using Luria-Bertani (LB) agar (Difco, 
BD Diagnostics, Franklin Lakes, NJ). The antimicrobial activity was determined by measuring the 
width of the inhibition zone. Three perpendicular measurements of the diameter per well were 
used to calculate the average inhibition diameter for each treatment. Assays were carried out in 
duplicate and repeated three times. 
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RESULTS AND DISCUSSION 
 
The antimicrobial activity of a LO solution was evaluated by applying increasing concentrations 
of the enzyme on media with different composition to evaluate the effect of lactose and SCN- on 
microbial growth inhibition. Results shown in Table 4 show that growth of all the indicators was 
inhibited when the LO solution was applied at a concentration of 12 g/L in presence of lactose 
alone and combined with NaSCN. Among the pathogens, S. aureus was found to be the most 
sensitive as it was the only species in the study that was inhibited at a concentration of 1.2 g/L of 
LO solution under optimal growth conditions.  
 
To determine if the generation of H2O2 was the cause of the antimicrobial activity, catalase was 
spotted next to the well to remove the compound where the inhibition zone would be formed. 
Results showed microbial growth on the area were the catalase was located for all the indicators 
(see Appendix). Based on these observations, it was concluded that the antimicrobial activity was 
attributed to the production of H2O2 as a product of lactose oxidation by LO. Other studies have 
attributed an antimicrobial effect to the production of hydrogen peroxide by lactobacilli (Price and 
Lee, 1970, Collins and Aramaki, 1980) and glucose oxidase present in honey (Mundo et al., 2004). 
 
With the exception of P. fragi, none of the microorganism in this study were inhibited on the 
control or the NaSCN-supplemented media at any level of LO, showing that the antimicrobial 
effect is mainly caused by the production of H2O2 in situ due to the oxidation of lactose, and not 
by any of the components of the enzymatic solution. Also, based on the standard deviations shown 
in Table 4, it can be argued that the addition of NaSCN had no influence on the antimicrobial effect 
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of the LO activity. This result contrasts previous results obtained in milk, where SCN- enhanced 
the antimicrobial activity of LO against P. fragi. This difference may attributable to differences in 
the distribution of the LO, homogenous in the milk vs diffusion in the agar, and the differences in 
the application and level of the bacterial load between the two studies. 
Table 4. Inhibition of growth of foodborne pathogens and spoilage microorganisms by lactose 
oxidase on BHI with different supplementations 
Indicator 
LO 
solution 
(g/L) 
Incubation 
temperature 
(°C) 
Zone of inhibition (mm) 
Control NaSCN Lactose 
NaSCN + 
Lactose 
E. coli 0.12 37 NI NI NI NI 
1.2 37 NI NI NI NI 
12 37 NI NI 3.9 ± 0.6 3.6 ± 0.4 
L. monocytogenes 0.12 6 NI NI NI NI 
1.2 6 NI NI 3.4 ± 0.3 4.1 ± 0.7 
12 6 NI NI 10.6 ± 0.6 9.4 ± 2.4 
0.12 37 NI NI NI NI 
1.2 37 NI NI NI NI 
12 37 NI NI 3.4 ± 0.4 3.1 ± 0.6 
S. aureus 0.12 37 NI NI NI NI 
1.2 37 NI NI 1.7 ± 0.9 1.8 ± 0.4 
12 37 NI NI 5.4 ± 0.6 5.1 ± 0.7 
S. enterica Ser. 
Tyhphimurium 
0.12 37 NI NI NI NI 
1.2 37 NI NI NI NI 
12 37 NI NI 4.5 ± 1.1 4.6 ± 0.4 
P. fragi 0.12 6 NI NI 2.9 ± 0.4 3.5 ± 0.5 
1.2 6 4.9 ± 0.1 4.1 ± 0.4 5.8 ± 0.5 6.5 ± 0.3 
12 6 7.7 ± 0.3 6.5 ± 0.4 8.0 ± 0.5 9.0 ± 0.8 
0.12 32 NI NI NI NI 
1.2 32 2.9 ± 0.8  2.8 ± 0.8 5.5 ± 0.3 5.4 ± 0.2 
12 32 7.1 ± 0.2 6.5 ± 0.3 7.4 ± 1.8 9.3 ± 0.8 
P. chrysogenum 0.12 25 NI NI NI NI 
1.2 25 NI NI NI NI 
12 25 NI NI 4.6 ± 0.1 5.2 ± 0.6 
NI: no inhibition 
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At 6 °C, P. fragi and L. monocytogenes showed higher sensitivity to the antimicrobial effect of LO 
than at their optimum growth temperature. L. monocytogenes was inhibited at a lower enzyme 
concentration (1.2 g/L) and the zone of inhibition at 12 g/L tripled. P. fragi was inhibited at the 
lowest concentration of LO solution (0.12 g/L). These findings are promising for applications of 
LO as a preservative in refrigerated products, since P. fragi and L. monocytogenes have the ability 
to grow at low temperatures and are one of the main causes of food spoilage (Ledenbach and 
Marshall, 2009) and recalls (CDC, 2018), respectively. 
 
As mentioned before, P. fragi was the only indicator inhibited on the control (BHI agar) and on 
NaSCN-supplemented media. Since bacterial growth was observed in the area where the catalase 
was spotted (Appendix, Figure 9 and Figure 10), the inhibition could potentially be attributed to 
the H2O2 produced from the oxidation of glucose, one of the components of BHI agar. Even though 
LO has high specificity for lactose as substrate, it is also able to oxidase other saccharides such as 
glucose, galactose, maltose, and cellobiose (Nordkvist et al., 2007). To confirm this effect, the 
overlay inhibition assay was replicated using LB agar since it does not contain any of those 
saccharides, and thus would preclude H2O2 production. On this media, P. fragi was not inhibited 
at any level of LO (Appendix, Figure 11) and thus supporting the conclusion that H2O2 production 
from the oxidation of glucose by LO was source of the inhibition observed in absence of lactose. 
The inhibition of Pseudomonas due to oxidation of a saccharide different than lactose propose that 
LO could be used as a preservative in food matrices with different sugar profiles where this 
particular spoilage organism is of concern.  
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LO also showed inhibition of P. chrysogenum growth in both media containing lactose. Other 
studies have reported antifungal activity of hydrogen peroxide against food spoilage molds like 
Penicillium expansum (Venturini et al., 2002) and Penicillium digitatum (Cerioni et al., 2009). It 
is important to mention that P. chrysogenum was also inhibited at 6 °C on both media containing 
lactose, however, it was not possible to measure a zone of inhibition because inhibition zones from 
different treatments merged (data not shown). As with P. fragi and L. monocytogenes, these results 
are promising for the application of LO as a preservative in refrigerated foods such as dairy 
products. 
 
  
  37 
CONCLUSION 
 
The broad antimicrobial activity of LO against foodborne pathogens and spoilage mold and 
bacteria, even under refrigerated conditions, suggest that LO could be applied as a novel food 
preservative in dairy products. Further investigation is required to develop applications 
considering the composition and processing of the product of interest. It is also necessary to assess 
the impact of LO on the sensory properties of the product. In addition, the microbial inhibition of 
LO against undesirable microorganisms associated other foods should be studied, as well as the 
impact of saccharides different than lactose on its antimicrobial activity. 
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CHAPTER 3 
OUTLOOKS AND PERSPECTIVES 
 
 
▪ In the first stages of the project, we tried to characterize lactose oxidase activity at different 
concentrations of both enzyme and lactose. Measurements were performed using an 
enzymatic assay kit (Fluorimetric Hydrogen Peroxide Assay Kit, Sigma Aldrich). Results 
from those experiments were not considered accurate enough to report them because of 
hydrogen peroxide being so unstable and because the lactose oxidation reaction was being 
carried out in presence of different reagents from the assay kit. However, results were used 
as reference to define the concentrations of lactose oxidase to be used in further 
experiments. 
 
▪ The application of lactose oxidase as an inhibitor of Listeria monocytogenes in queso fresco 
was tested dipping previously inoculated cheese in solutions with different concentrations 
of lactose oxidase for 1 minute. Cheese was then vacuum sealed in plastic bags (Food 
Saver) and stored under refrigeration. The enzymatic treatment was not effective probably 
due to lack of oxygen necessary for lactose oxidase activity. However, other factors that 
could potentially affect the results are concentration of lactose in the cheese, concentration 
of lactose oxidase, and dipping time. Other application methods such as coatings or 
incorporating the enzyme at some point during cheese processing could be studied. 
 
▪ The effect of lactose oxidase as a brine preservative should be further studied. Preliminary 
experiments showed antibacterial activity against Listeria monocytogenes in commercial 
Feta cheese brines even without lactose supplementation. However, it showed no activity 
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in a commercial Mozzarella cheese brine. We suggest performing studies with brines 
prepared in the laboratory to control for their composition and other variables that may 
affect the effectiveness of the enzyme as an antimicrobial. 
 
▪ Based on results from this study, the concentration of NaSCN should be considered in the 
development of further applications of lactose oxidase. Also, this compound could be 
added as a vegetable extract or as a sub-product of milk ultrafiltration to prevent a negative 
impact on the list of ingredients of the final product; given the current trend for clean-label 
products. 
 
▪ Lactose oxidase immobilization can be studied as a solution to the pH drop caused by the 
enzyme during shelf-life in pasteurized milk. A possibility is to immobilize the enzyme on 
a surface and pass the milk through it before pasteurization. In this way, the antimicrobial 
effect by hydrogen peroxide and by the activation of the LPS could be achieved preventing 
migration of the enzyme to the final product. In addition, in case of enzyme migration to 
the milk, it would be inactivated with subsequent pasteurization. 
 
▪ The application of lactose oxidase as a preservative could be studied in non-dairy products 
since it showed antimicrobial activity as a result of glucose oxidation. Potential 
applications could be for example, acidified beverages or fruit juices. 
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APENDIX 
 
 
Figure 5. Inhibition of Escherichia coli by lactose oxidase at 37 ºC on BHI agar with (A) 2.5 % 
lactose and (B) 2.5 % lactose and 14 mg/L NaSCN. 
 
 
Figure 6. Inhibition of Listeria monocytogenes by lactose oxidase at 37 ºC on BHI agar with (A) 
2.5 % lactose and (B) 2.5 % lactose and 14 mg/L NaSCN. 
 
 
Figure 7. Inhibition of Salmonella enterica Ser. Typhimurium by lactose oxidase at 37 ºC on 
BHI agar with (A) 2.5 % lactose and (B) 2.5 % lactose and 14 mg/L NaSCN. 
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A B
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Figure 8. Inhibition of Staphylococcus aureus by lactose oxidase at 37 ºC on BHI agar with (A) 
2.5 % lactose and (B) 2.5 % lactose and 14 mg/L NaSCN. 
 
 
 
Figure 9. Inhibition of Pseudomonas fragi by lactose oxidase at 32 ºC on BHI agar with (A) no 
supplementation (control) (B) 14 mg/L NaSCN (C) 2.5 % lactose and (D) 2.5 % lactose and 14 
mg/L NaSCN. 
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Figure 10. Inhibition of Pseudomonas fragi by lactose oxidase at 6 ºC on BHI agar with (A) no 
supplementation (control) (B) 14 mg/L NaSCN (C) 2.5 % lactose and (D) 2.5 % lactose and 14 
mg/L NaSCN. 
 
Figure 11. Pseudomonas fragi on LB agar treated with lactose oxidase and incubated at 32 ºC. 
 
Figure 12. Inhibition of Penicillium chrysogenum by lactose oxidase at 37 ºC on BHI agar with 
(A) 2.5 % lactose and (B) 2.5 % lactose and 14 mg/L NaSCN. 
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